HPV-driven oropharyngeal cancers have significantly better survival rates than tobacco and
alcohol induced head and neck cancers. As HPV-positive patients are younger, healthier …

Evidence for transcriptional activation of the viral oncoproteins E6 and E7 is regarded as the
gold standard for the presence of clinically relevant human papillomavirus (HPV), but …

The prototypic head and neck squamous cell carcinoma (HNSCC) arises from the mucosal
lining of the upper aerodigestive tract, demonstrates squamous differentiation …

BACKGROUND: Human papillomavirus (HPV) is a causative agent in a subset of head and
neck squamous cell carcinomas (HNSCCs). These HPV‐related cancers have a …

Human papillomavirus (HPV) is etiologically responsible for a distinct subset of head and
neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most …

Background Immune checkpoint inhibitors (ICI) are approved for treatment of recurrent or
metastatic oropharyngeal head and neck squamous cell carcinoma in the first-and second …

Human papillomavirus (HPV) infection is causally associated with benign and malignant
diseases of the upper airway, including respiratory papillomatosis and oropharyngeal …

Background In the human papillomavirus (HPV) era, the best way to assess oropharyngeal
squamous carcinomas (SCC) for risk stratification is not clear. Many recommend use of both …

Background Sexual contact may be the means by which head and neck cancer patients are
exposed to human papillomavirus (HPV). Methods We undertook a pooled analysis of four …

Human papillomavirus (HPV) is a necessary cause of cervical cancer. In addition, on the
basis of the fulfillment of a combination of viral as well as epidemiological criteria, it is …